ALKERMES PLC's ticker is ALKS and the CUSIP is G01767105. A total of 274 filers reported holding ALKERMES PLC in Q4 2022. The put-call ratio across all filers is 2.58 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $27,018,278 | +26.6% | 964,594 | +41.5% | 0.03% | +27.3% |
Q2 2023 | $21,334,674 | +70.3% | 681,619 | +53.4% | 0.02% | +69.2% |
Q1 2023 | $12,524,253 | -16.1% | 444,280 | -22.2% | 0.01% | -23.5% |
Q4 2022 | $14,929,480 | +169.3% | 571,354 | +130.2% | 0.02% | +142.9% |
Q3 2022 | $5,543,000 | -32.3% | 248,242 | -9.7% | 0.01% | -30.0% |
Q2 2022 | $8,188,000 | +420.2% | 274,861 | +359.3% | 0.01% | +900.0% |
Q1 2022 | $1,574,000 | -64.2% | 59,842 | -68.3% | 0.00% | -75.0% |
Q4 2021 | $4,394,000 | +84.8% | 188,898 | +145.0% | 0.00% | +100.0% |
Q3 2021 | $2,378,000 | -45.1% | 77,094 | -56.3% | 0.00% | -50.0% |
Q2 2021 | $4,329,000 | +251.7% | 176,537 | +167.8% | 0.00% | +300.0% |
Q1 2021 | $1,231,000 | -84.8% | 65,911 | -83.8% | 0.00% | -85.7% |
Q4 2020 | $8,121,000 | -31.5% | 407,096 | -43.1% | 0.01% | -41.7% |
Q3 2020 | $11,850,000 | +6.9% | 715,130 | +25.2% | 0.01% | -7.7% |
Q2 2020 | $11,081,000 | -11.9% | 570,989 | -34.6% | 0.01% | -35.0% |
Q1 2020 | $12,582,000 | -41.8% | 872,492 | -17.6% | 0.02% | -20.0% |
Q4 2019 | $21,603,000 | +68.2% | 1,058,938 | +60.9% | 0.02% | +56.2% |
Q3 2019 | $12,843,000 | -29.7% | 658,286 | -18.8% | 0.02% | -30.4% |
Q2 2019 | $18,276,000 | +44.0% | 810,821 | +133.2% | 0.02% | +43.8% |
Q1 2019 | $12,690,000 | +274.3% | 347,758 | +202.7% | 0.02% | +220.0% |
Q4 2018 | $3,390,000 | -29.1% | 114,873 | +2.0% | 0.01% | -16.7% |
Q3 2018 | $4,781,000 | +103.1% | 112,645 | +97.0% | 0.01% | +100.0% |
Q2 2018 | $2,354,000 | -47.7% | 57,182 | -26.3% | 0.00% | -50.0% |
Q1 2018 | $4,497,000 | -55.4% | 77,596 | -57.9% | 0.01% | -57.1% |
Q4 2017 | $10,078,000 | -64.1% | 184,144 | -66.7% | 0.01% | -67.4% |
Q3 2017 | $28,079,000 | -38.8% | 552,302 | -30.2% | 0.04% | -43.4% |
Q2 2017 | $45,878,000 | -12.0% | 791,406 | -11.2% | 0.08% | -17.4% |
Q1 2017 | $52,122,000 | +12.7% | 890,970 | +7.1% | 0.09% | +16.5% |
Q4 2016 | $46,231,000 | -41.0% | 831,790 | -50.1% | 0.08% | -42.8% |
Q3 2016 | $78,345,000 | +29.3% | 1,665,836 | +18.8% | 0.14% | +23.2% |
Q2 2016 | $60,586,000 | +83.9% | 1,401,817 | +45.4% | 0.11% | +89.8% |
Q1 2016 | $32,953,000 | +55.6% | 963,834 | +261.3% | 0.06% | +84.4% |
Q4 2015 | $21,176,000 | +2074.1% | 266,770 | +1506.7% | 0.03% | +3100.0% |
Q3 2015 | $974,000 | -92.0% | 16,604 | -91.2% | 0.00% | -94.4% |
Q2 2015 | $12,138,000 | -21.0% | 188,649 | -25.2% | 0.02% | -25.0% |
Q1 2015 | $15,368,000 | +4.7% | 252,063 | +0.6% | 0.02% | +26.3% |
Q4 2014 | $14,680,000 | +22.3% | 250,684 | -10.4% | 0.02% | +18.8% |
Q3 2014 | $11,999,000 | -35.5% | 279,896 | -24.3% | 0.02% | -38.5% |
Q2 2014 | $18,602,000 | -36.6% | 369,595 | -44.5% | 0.03% | -36.6% |
Q1 2014 | $29,342,000 | +10.8% | 665,502 | +2.2% | 0.04% | +10.8% |
Q4 2013 | $26,486,000 | +103.2% | 651,391 | +68.0% | 0.04% | +76.2% |
Q3 2013 | $13,032,000 | +160.8% | 387,639 | +122.5% | 0.02% | +133.3% |
Q2 2013 | $4,997,000 | – | 174,244 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Woodford Investment Management Ltd | 2,639,676 | $96,322,000 | 7.78% |
Meditor Group Ltd | 892,400 | $32,564,000 | 6.11% |
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 233,000 | $8,502,000 | 3.14% |
Tamarack Advisers, LP | 140,000 | $5,109,000 | 2.03% |
Asymmetry Capital Management, L.P. | 27,673 | $1,010,000 | 1.69% |
First Light Asset Management, LLC | 211,164 | $7,705,000 | 1.00% |
BOGLE INVESTMENT MANAGEMENT L P /DE/ | 304,992 | $11,129,000 | 0.85% |
Nicollet Investment Management, Inc. | 28,020 | $1,022,000 | 0.67% |
PRIMECAP MANAGEMENT CO/CA/ | 23,263,530 | $848,886,000 | 0.62% |
Rhenman & Partners Asset Management AB | 120,399 | $4,393,000 | 0.51% |